Coxsackie Adenovirus Receptor anticorps (AA 300-335)
Aperçu rapide pour Coxsackie Adenovirus Receptor anticorps (AA 300-335) (ABIN1978195)
Antigène
Voir toutes Coxsackie Adenovirus Receptor (CXADR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 300-335
-
Specificité
- Region between residue 300 and 335 of human Coxsackievirus and Adenovirus Receptor Protein using the numbering given in entry NP_001329.1 (GeneID 1525).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IF (1:50 - 1:250), IHC, IHC-P (1:100 - 1:500), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Ovarian Carcinoma. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- Coxsackie Adenovirus Receptor (CXADR) (Coxsackie Virus and Adenovirus Receptor (CXADR))
-
Autre désignation
- CXADR
-
Sujet
-
Name/Gene ID: CXADR
Synonyms: CXADR, CAR4/6, Coxsackie-adenovirus receptor, CVB3-binding protein, CAR, HCAR, HCVADR -
ID gène
- 1525
-
Pathways
- Cell-Cell Junction Organization
Antigène
-